Drugs / Peginterferon α1b
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05492591 | Oct 2022 → Jul 2023 | herpes zoster | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peginterferon α1b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05492591 ↗ |
| Route | Subcutaneous | “multiple subcutaneous injections of peginterferon α1b” NCT05492591 ↗ |